Facial Injectables Market Report - Global Forecasts to 2023
Global Facial Injectables Market by Products (Botox, Dermal Fillers) by End Users (Hospitals, Dermatology Centers, Physician's Office) Drivers, Opportunities, Trends, and Forecasts: 2017-2023
Skin provides a protective barrier to the body by covering all the core structures and is the largest organ in the human body. Skin acts as a mechanical barrier for harmful UV rays and plays a vital role in thermoregulation and water homeostasis. Aging is one of the direct comparisons of the chronological changes in the face, hair, body, and all the visible characteristics that are found comparative. Every individual face ages on its own speed and depends on various environmental factors. However, some basic characteristics are common and natural: loss of a proportion of the skin, glabellar lines, sagging of the eyebrows, sunken eyes, wrinkles, irregular skin surfaces, loss of lip volume, irregular chin contour, and skin discoloration. Apart from aging, the new generation has attracted towards cosmetic industry to look aesthetic and appear more youthful. Most of the advancements made in the dermatology field are to treat various skin diseases and enhance the quality of the skin. The advent of facial injectables has revolutionized the cosmetic industry by providing an individual the most important part of life, which is to look youthful and beautiful.
The factors such as increase in beauty consciousness, growing awareness about facial injections, increasing demand for non-surgical and minimally invasive cosmetic surgeries, and anticipated launch of new products are expected to drive the market growth during the forecast period. The market is witnessing the emerging trends such as increase in demand for combination treatments, rise in medical tourism, and increase in disposable income that will drive the market at a significant pace during the forecast period. The markets in Brazil, India, China, and Russia are expected to grow at a rapid pace during the forecast period as the adoption of cosmetic procedures in these countries is high.
The “Global Facial Injectables Market” is estimated to witness a CAGR of 10.42% during the forecast period 2017–2023. The market is analyzed based on three segments – product type, end-users, and regions.
The market is monopolistic and dominated by Allergan, which has more than 45% market share in the total global facial injectables market size. It is further fragmented with the presence of many global and local players. The factors such as increased prevalence of skin related disorders, growing popularity about spas and beauty clinics, focus on improving facial appearances, increasing adoption of non-invasive cosmetic surgeries, and increasing disposable income are driving the market growth.
The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). The Americas is set to be the leading region for the facial injectables market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. Brazil is set to be the most attractive destination, and in Latin America, the popularity and the usage of facial injectables are expected to increase in the coming years.
Botox and dermal fillers are the most popular treatments among all class of people and have become the most common aesthetic procedures among end-users. Botox dominated the market, while dermal fillers segment is positioned above due to the huge adoption of a wide variety of fillers owing to its growing use in many areas. In 2016, there were about 7.05 million injections of botulinum toxin worldwide. It is because of the shift in cultural thinking, high spending on beauty products, and increased brand popularity.
The major products in the market include:
- Restylane – Hyaluronic Acid-Based Filler
- Juvederm – Hyaluronic Acid-Based Filler
- PREVELLE Silk – Hyaluronic Acid-Based Filler
- Hydrelle – Hyaluronic Acid-Based Filler
- Belotero – Hyaluronic Acid-Based Filler
- Cosmoplast – Collagen-Based Fillers
- Evolence – Collagen-Based Fillers
- Sculptra – Semi-Permanent Fillers
- Radiesse – Semi-Permanent Fillers
- ArteFill – Permanent Fillers
- BOTOX – OnabotulinumtoxinA
- Dysport – AbobotulinumtoxinA
- Xeomin – IncobotulinumtoxinA
- Myobloc – RimabotulinumtoxinB
On an average, women have started spending $300–$500 billion a year on beauty products. Moreover, advances in technologies such as injecting techniques and molecular changes adopted in filler materials have brought safe and simple methods in performing facial injections to patients. Further, the market is also witnessing various mergers, acquisitions, and collaborations among the top players, which are defining the future of the Global Facial Injectables market.
Allergan plc, Galderma S.A., Merz Pharma Gmbh & Co. KGaA, Merck & Co. Inc., Ipsen S.A., and other predominate & niche players.
The Global Facial Injectables market is highly fragmented and has immense growth opportunities for vendors, especially in the developed regions. The presence of large, small, and local vendors in the market possess high competition. The market is dominated by Allergan, Galderma, Merz Pharma, and Ipsen. These vendors have a strong focus on acquiring smaller companies and expanding their business operations by leveraging their products portfolio across the globe. The competitive environment in the market will intensify further with an increase in product/service extensions, product innovations, and M&As. They form strategic alliances for the marketing or manufacturing of facial injectables products.
The report provides complete details about the usage and adoption rate of facial injectables in various dermatology treatments. With that, key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, government initiatives towards the facial injectables adoption in the upcoming years along with the details of pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
1 Report Outline
1.1 Report Scope
1.2 Market Definitions
1.3 Research Methodology
1.4 Report Assumptions and Declarations
2 Executive Summary
3 Market Positioning
3.1 Total Addressable Market (TAM): Medical Aesthetics Industry
3.2 Segmented Addressable Market (SAM): Facial Injectables Market
3.2.1 Market Overview
3.2.2 Major Trends
3.2.3 PEST Analysis
3.3 Related Markets
4 Market Outlook
4.2 Value Chain Analysis
4.3 Market Segmentation
4.4 Porter 5 (Five) Forces Analysis
4.5 Raw Material Analysis
4.6 Patents Analysis
5 Market Characteristics
5.2 Market Segmentation
5.3 Market Dynamics
5.3.4 DRO – Impact Analysis
6 Facial Injectables Market by Types: Market Size and Analysis
6.2 Dermal Fillers
7 Facial Injectables Market by End Users: Market Size and Analysis
7.3 Dermatology Centers
7.4 Physician’s Office
8 Facial Injectables Market by Regions: Market Size and Analysis
8.2 The Americas
8.3 The EMEA Region
8.4 The APAC region
9 Competitive Landscape
10 Vendor Profiles
10.1 Allergan Plc
10.2 Galderma S.A.
10.3 Merz Pharma GmbH & Co. KGaA
10.4 Ipsen S.A.
(Overview, products/services, geographic revenues, recent developments, business focus, SWOT analysis and business strategy for all vendors)
11 Companies to Watch For
11.1 Sinclair Pharma Plc
11.2 Bloomage Biotechnology Corp. Ltd.
11.3 Valeant Pharmaceuticals International Inc.
(Overview, product coverage and potential, geographic exposure, recent developments, and business strategy for all players)
TABLE 1 AVERAGE COST OF DERMAL FACIAL FILLERS
TABLE 2 GLOBAL FACIAL INJECTABLES MARKET BY TYPES, 2016–2023 ($MILLION)
TABLE 3 DRO OF DERMAL FILLERS MARKET
TABLE 4 DRO OF BOTOX MARKET
TABLE 5 GLOBAL FACIAL INJECTABLES MARKET REVENUE FORECAST BY REGION, 2017–2023 ($MILLION)
TABLE 6 DRO (NORTH AMERICA)
TABLE 7 DRO (EUROPE)
TABLE 8 DRO (APAC)
TABLE 9 DRO (REST OF THE WORLD)
TABLE 10 GLOBAL FACIAL INJECTABLES MARKET BY VENDOR RANKING, 2016
TABLE 11 ALLERGAN PLC: PRODUCT OFFERINGS
TABLE 12 ALLERGAN PLC: RECENT DEVELOPMENTS
TABLE 13 GALDERMA S.A.: PRODUCT OFFERINGS
TABLE 14 GALDERMA S.A.: RECENT DEVELOPMENTS
TABLE 15 MERZ PHARMA GMBH & CO. KGAA: PRODUCT OFFERINGS
TABLE 16 MERZ PHARMA GMBH & CO. KGAA: RECENT DEVELOPMENTS
TABLE 17 IPSEN S.A.: PRODUCT OFFERINGS
TABLE 18 IPSEN S.A.: RECENT DEVELOPMENTS
TABLE 19 SINCLAIR PHARMA PLC: SNAPSHOT
TABLE 20 SINCLAIR PHARMA PLC: RECENT DEVELOPMENTS
TABLE 21 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: SNAPSHOT
TABLE 22 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: RECENT DEVELOPMENTS
TABLE 23 VALEANT PHARMACEUTICALS INTERNATIONAL INC: SNAPSHOT
TABLE 24 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: RECENT DEVELOPMENTS
TABLE 25 OTHER VENDORS
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.